Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice (Q58530355)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tomi P. Mäkelä

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

Caj Haglund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Alexandra Thiel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Kirsi Narko

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mira Heinonen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Annabrita Hemmes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Marie-Christine Rio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ari Ristimäki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

14 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1032-1041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

15 January 2020

cites work

1 reference

Cyclooxygenase‐2 and gastric carcinogenesis

21 January 2018

1 reference

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward

21 January 2018

1 reference

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

21 January 2018

1 reference

Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection.

21 January 2018

1 reference

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

21 January 2018

1 reference

Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice.

21 January 2018

1 reference

Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.

21 January 2018

1 reference

Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein

21 January 2018

1 reference

Trefoil factors: initiators of mucosal healing

21 January 2018

1 reference

Pleiotropic effects of Trefoil Factor 1 deficiency

21 January 2018

1 reference

pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study.

21 January 2018

1 reference

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

21 January 2018

1 reference

Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling

21 January 2018

1 reference

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

Prostaglandin E₂ signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors

21 January 2018

1 reference

The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance

21 January 2018

1 reference

Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer

21 January 2018

1 reference

Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.

21 January 2018

1 reference

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

21 January 2018

1 reference

Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice

21 January 2018

1 reference

Gastric mucosal defense and cytoprotection: bench to bedside

21 January 2018

1 reference

Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis

21 January 2018

1 reference

TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury

21 January 2018

1 reference

Cyclooxygenase-2 expression during carcinogenesis in the human stomach.

21 January 2018

1 reference

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

21 January 2018

1 reference

Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma

21 January 2018

1 reference

Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.

21 January 2018

1 reference

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

The COXIB experience: a look in the rearview mirror

21 January 2018

1 reference

21 January 2018

1 reference

A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells

21 January 2018

1 reference

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22034055%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference